vs
Side-by-side financial comparison of CB Financial Services, Inc. (CBFV) and CHAMPIONS ONCOLOGY, INC. (CSBR). Click either name above to swap in a different company.
CHAMPIONS ONCOLOGY, INC. is the larger business by last-quarter revenue ($15.0M vs $13.8M, roughly 1.1× CB Financial Services, Inc.). On growth, CB Financial Services, Inc. posted the faster year-over-year revenue change (19.9% vs 11.5%). CB Financial Services, Inc. produced more free cash flow last quarter ($17.2M vs $-2.0M). Over the past eight quarters, CHAMPIONS ONCOLOGY, INC.'s revenue compounded faster (11.8% CAGR vs 1.2%).
CB Bank is one of Myanmar's largest commercial banks. It became the first bank in Myanmar to issue ATM cards and credit cards. The bank, led by U Khin Maung Aye (Chairman) and U Kyaw Thu Ko (CEO) has over 245 branches across the country.
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist.
CBFV vs CSBR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $15.0M |
| Net Profit | — | $268.0K |
| Gross Margin | — | 51.7% |
| Operating Margin | 38.1% | 1.2% |
| Net Margin | — | 1.8% |
| Revenue YoY | 19.9% | 11.5% |
| Net Profit YoY | — | -63.2% |
| EPS (diluted) | $0.90 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $15.0M | ||
| Q3 25 | $2.4M | $14.0M | ||
| Q2 25 | $13.5M | $12.4M | ||
| Q1 25 | $12.1M | $17.0M | ||
| Q4 24 | $13.2M | $13.5M | ||
| Q3 24 | $12.7M | $14.1M | ||
| Q2 24 | $12.2M | $14.0M | ||
| Q1 24 | $13.5M | $12.0M |
| Q4 25 | — | $268.0K | ||
| Q3 25 | $-5.7M | $-436.0K | ||
| Q2 25 | $3.9M | $-1.8M | ||
| Q1 25 | $1.9M | $4.5M | ||
| Q4 24 | — | $728.0K | ||
| Q3 24 | $3.2M | $1.3M | ||
| Q2 24 | $2.6M | $-109.0K | ||
| Q1 24 | $4.2M | $-2.5M |
| Q4 25 | — | 51.7% | ||
| Q3 25 | — | 42.9% | ||
| Q2 25 | — | 41.1% | ||
| Q1 25 | — | 61.2% | ||
| Q4 24 | — | 44.9% | ||
| Q3 24 | — | 49.7% | ||
| Q2 24 | — | 48.2% | ||
| Q1 24 | — | 34.7% |
| Q4 25 | 38.1% | 1.2% | ||
| Q3 25 | -289.8% | -3.8% | ||
| Q2 25 | 35.0% | -16.2% | ||
| Q1 25 | 19.3% | 26.4% | ||
| Q4 24 | 23.1% | 5.4% | ||
| Q3 24 | 31.2% | 9.5% | ||
| Q2 24 | 26.4% | -1.9% | ||
| Q1 24 | 37.9% | -21.4% |
| Q4 25 | — | 1.8% | ||
| Q3 25 | -235.2% | -3.1% | ||
| Q2 25 | 29.3% | -14.9% | ||
| Q1 25 | 15.8% | 26.4% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | 25.3% | 9.3% | ||
| Q2 24 | 21.8% | -0.8% | ||
| Q1 24 | 31.1% | -21.1% |
| Q4 25 | $0.90 | $0.02 | ||
| Q3 25 | $-1.07 | $-0.03 | ||
| Q2 25 | $0.74 | $-0.12 | ||
| Q1 25 | $0.35 | $0.31 | ||
| Q4 24 | $0.45 | $0.05 | ||
| Q3 24 | $0.60 | $0.09 | ||
| Q2 24 | $0.51 | $-0.01 | ||
| Q1 24 | $0.82 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $8.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $157.5M | $4.2M |
| Total Assets | $1.5B | $30.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $8.5M | ||
| Q3 25 | $55.9M | $10.3M | ||
| Q2 25 | $64.5M | $9.8M | ||
| Q1 25 | $61.3M | $3.2M | ||
| Q4 24 | $49.6M | $2.8M | ||
| Q3 24 | $147.3M | $2.9M | ||
| Q2 24 | $142.6M | $2.6M | ||
| Q1 24 | $73.7M | $4.5M |
| Q4 25 | $157.5M | $4.2M | ||
| Q3 25 | $152.5M | $3.5M | ||
| Q2 25 | $148.4M | $3.8M | ||
| Q1 25 | $148.3M | $5.5M | ||
| Q4 24 | $147.4M | $681.0K | ||
| Q3 24 | $149.1M | $-332.0K | ||
| Q2 24 | $142.9M | $-1.9M | ||
| Q1 24 | $141.6M | $-2.1M |
| Q4 25 | $1.5B | $30.2M | ||
| Q3 25 | $1.5B | $30.5M | ||
| Q2 25 | $1.5B | $32.3M | ||
| Q1 25 | $1.5B | $30.6M | ||
| Q4 24 | $1.5B | $25.2M | ||
| Q3 24 | $1.6B | $24.9M | ||
| Q2 24 | $1.6B | $26.1M | ||
| Q1 24 | $1.5B | $26.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $17.8M | $-1.7M |
| Free Cash FlowOCF − Capex | $17.2M | $-2.0M |
| FCF MarginFCF / Revenue | 124.1% | -13.1% |
| Capex IntensityCapex / Revenue | 4.7% | 1.6% |
| Cash ConversionOCF / Net Profit | — | -6.47× |
| TTM Free Cash FlowTrailing 4 quarters | $29.5M | $5.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.8M | $-1.7M | ||
| Q3 25 | $4.6M | $600.0K | ||
| Q2 25 | $4.1M | $6.9M | ||
| Q1 25 | $4.0M | $490.0K | ||
| Q4 24 | $6.8M | $-283.0K | ||
| Q3 24 | $3.1M | $311.0K | ||
| Q2 24 | $-1.2M | $-1.8M | ||
| Q1 24 | $3.3M | $-919.0K |
| Q4 25 | $17.2M | $-2.0M | ||
| Q3 25 | $4.5M | $554.0K | ||
| Q2 25 | $3.9M | $6.6M | ||
| Q1 25 | $3.9M | $448.0K | ||
| Q4 24 | $3.4M | $-377.0K | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $-2.4M | $-1.8M | ||
| Q1 24 | $2.3M | $-1.0M |
| Q4 25 | 124.1% | -13.1% | ||
| Q3 25 | 186.5% | 4.0% | ||
| Q2 25 | 28.8% | 53.5% | ||
| Q1 25 | 32.5% | 2.6% | ||
| Q4 24 | 26.0% | -2.8% | ||
| Q3 24 | 17.4% | — | ||
| Q2 24 | -19.6% | -13.0% | ||
| Q1 24 | 17.0% | -8.4% |
| Q4 25 | 4.7% | 1.6% | ||
| Q3 25 | 4.3% | 0.3% | ||
| Q2 25 | 1.9% | 2.0% | ||
| Q1 25 | 0.8% | 0.2% | ||
| Q4 24 | 25.1% | 0.7% | ||
| Q3 24 | 6.7% | 0.0% | ||
| Q2 24 | 10.0% | 0.0% | ||
| Q1 24 | 7.2% | 0.8% |
| Q4 25 | — | -6.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 2.11× | 0.11× | ||
| Q4 24 | — | -0.39× | ||
| Q3 24 | 0.95× | 0.24× | ||
| Q2 24 | -0.44× | — | ||
| Q1 24 | 0.78× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBFV
Segment breakdown not available.
CSBR
| Pharmacology Services | $14.5M | 97% |
| Other | $520.0K | 3% |
